Melchior C. Nierman

1.6k citations

32 papers · 1.1k indexed · 1 hit paper · h-index 15

Cardiology and Cardiovascular Medicine top 5%
- Atrial Fibrillation Management and Outcomes 10
- Lipid metabolism and disorders 9
- Blood Pressure and Hypertension Studies 5
Endocrinology, Diabetes and Metabolism top 5%
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
Internal Medicine top 5%
Family Practice top 10%
Surgery top 10%
- Lipoproteins and Cardiovascular Health 8
- Heparin-Induced Thrombocytopenia and Thrombosis 3
Cancer Research
- Cancer, Lipids, and Metabolism 5
Genetics
- Diabetes and associated disorders 4

Co-authors: John J.P. Kastelein Erik S.G. Stroes Patrick Duriez Jean‐Charles Fruchart Jan Albert Kuivenhoven Jaap Rip Michael R. Hayden Colin J.D. Ross
Cited by: Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Internal Medicine
Journals: Arteriosclerosis Thrombosis and Vascular Biology (4 papers)Research and Practice in Thrombosis and Haemostasis (3 papers)Journal of Thrombosis and Haemostasis (3 papers)
Partner nations: Netherlands United Kingdom Canada

In The Last Decade

Melchior C. Nierman

27 papers receiving 1.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Melchior C. Nierman

Since Specialization

Citations

This map shows the geographic impact of Melchior C. Nierman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melchior C. Nierman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melchior C. Nierman more than expected).

Fields of papers citing papers by Melchior C. Nierman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melchior C. Nierman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melchior C. Nierman. The network helps show where Melchior C. Nierman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Melchior C. Nierman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Melchior C. Nierman Line = papers co-authored together Melchior C. Nierman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Changes in quality of vitamin K antagonist treatment and clinical outcomes during Ramadan: a Dutch population-based cohort study Research and Practice in Thrombosis and Haemostasis ·Bernhard Ds,Qingui Chen,Nienke van Rein,Ferdows Atiq,Roger K. Schindhelm,H. Sztuder,C.E.A. Dronkers,Uyanik Ismail,Arina J. ten Cate‐Hoek,Melchior C. Nierman,Alexander Stork,عبدالفتاح بهيج عبدالدايم العواري,Frederikus A. Klok,Suzanne C. Cannegieter,Marieke J.H.A. Kruip	2025	0
2	YEARS clinical decision rule for diagnosing pulmonary embolism: a prospective diagnostic cohort follow-up study in primary care BMJ Open ·K. Carter,Dengke Pan,Frans H. Rutten,Melchior C. Nierman,Frederikus A. Klok,Menno V. Huisman,A. Boyal,Jeanet W. Blom,Karel G. M. Moons,Geert‐Jan Geersing	2025	0
3	Enhanced identification of familial hypercholesterolemia using central laboratory algorithms Atherosclerosis ·Popandopulo Ksenia Dmitrievna,Nick S. Nurmohamed,Melchior C. Nierman,宋泽斌,Linda Zuurbier,Jeroen van Rooij,Oscar Armenta Estrela,Sebastian Fries,G. Kees Hovingh,Laurens F. Reeskamp,Erik S.G. Stroes	2024	1
4	A prospective study investigating the relation between blood‐based biomarkers for Alzheimer’s disease and diagnosis/patient management in primary care: The CANTATE‐PC study Alzheimer s & Dementia ·Dong-Kyun Seo,W. M. Rost,Inge M.W. Verberk,Anouk den Braber,J.A. Tovar Larrucea,David Wilson,Melchior C. Nierman,Jurgen Kooren,Wiesje M. van der Flier,Argonde C. van Harten,Charlotte E. Teunissen	2023	0
5	The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists Thrombosis Research ·S. Lüpfert,A. Trigueros,Melchior C. Nierman,Menno V. Huisman,Laila Zakaria Ismail ABDEL-HAMID,C. Heleen van Ommen,Marieke J.H.A. Kruip	2023	1
6	ZorgDomein als oplossing bij inclusieproblemen Huisarts en Wetenschap ·K. Carter,Frans H. Rutten,Jeanet W. Blom,Jeong-Han Song,Jochen Cals,Melchior C. Nierman,Geert‐Jan Geersing	2023	0
7	Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis Research and Practice in Thrombosis and Haemostasis ·Oskar Schütz,Nienke van Rein,F.J.M. van der Meer,Melchior C. Nierman,Willem M. Lijfering,Suzanne C. Cannegieter	2021	4
8	Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study Journal of Thrombosis and Haemostasis ·Jackie Davis,Nienke van Rein,Melchior C. Nierman,ایمان مهرابی دستنابی,Menno V. Huisman,F.J.M. van der Meer,Suzanne C. Cannegieter,Willem M. Lijfering	2021	24
9	Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence? Journal of Thrombosis and Haemostasis ·Jackie Davis,Qingui Chen,Marieke J.H.A. Kruip,F.J.M. van der Meer,Melchior C. Nierman,Laura M. Faber,Eleonora Dallan,Suzanne C. Cannegieter,Willem M. Lijfering	2021	6
10	Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants Research and Practice in Thrombosis and Haemostasis ·Jackie Davis,Nienke van Rein,Melchior C. Nierman,ایمان مهرابی دستنابی,Menno V. Huisman,F.J.M. van der Meer,Suzanne C. Cannegieter,Willem M. Lijfering	2020	18
11	Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns Journal of Thrombosis and Haemostasis ·Jackie Davis,Nienke van Rein,Melchior C. Nierman,ایمان مهرابی دستنابی,Menno V. Huisman,F.J.M. van der Meer,Suzanne C. Cannegieter,Willem M. Lijfering	2020	11
12	Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial BMJ Open ·Aulia Yusran,Sander van Doorn,Arno W. Hoes,Melchior C. Nierman,Yohanes Fransiskus Mite Ngole,Huiberdina L. Koek,Martin E W Hemels,Menno V. Huisman,Kit C. B. Roes,Zeynep Mennan,Hua-Tz Tzeng,Frans H. Rutten,Geert‐Jan Geersing	2019	11
13	Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk The American Journal of Cardiology ·Pythia T. Nieuwkerk,Melchior C. Nierman,Maud N. Vissers,Yongzheng Qi,Ocal Kanber,Sunday Ayodele Ige,John J.P. Kastelein,Mirjam A. G. Sprangers,Hanneke C. de Haes,Erik S.G. Stroes	2012	55
14	Intramuscular Administration of AAV1-Lipoprotein Lipase ^S447X Lowers Triglycerides in Lipoprotein Lipase–Deficient Patients Arteriosclerosis Thrombosis and Vascular Biology ·Erik S.G. Stroes,Melchior C. Nierman,J. J. M. Meulenberg,Remco Franssen,Jaap Twisk,C. P. Henny,Mario Maas,Aeilko H. Zwinderman,Colin J.D. Ross,Eleonora Aronica,Katherine A. High,Marcel M. Levi,Michael R. Hayden,John J.P. Kastelein,Jan Albert Kuivenhoven	2008	145
15	Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia Journal of Lipid Research ·Frank G. Schaap,Melchior C. Nierman,Jimmy F.P. Berbée,Hiroaki Hattori,Philippa J. Talmud,Stefan F.C. Vaessen,Patrick C.N. Rensen,Robert A.F.M. Chamuleau,Jan Albert Kuivenhoven,Albert K. Groen	2006	46
16	Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia Acta Paediatrica ·Anouk van der Graaf,Melchior C. Nierman,Jean Firth,Karen Wolmarans,A. David Marais,Eric de Groot	2006	36
17	Lipoprotein Lipase S447X Arteriosclerosis Thrombosis and Vascular Biology ·Jaap Rip,Melchior C. Nierman,Colin J.D. Ross,J. Wouter Jukema,Michael R. Hayden,John J.P. Kastelein,Erik S.G. Stroes,Jan Albert Kuivenhoven	2006	124
18	Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance Metabolism ·Melchior C. Nierman,Jaap Rip,F. Gyuru,Daniël H. van Raalte,Barbara A. Hutten,Naohiko Sakai,John J.P. Kastelein,Erik S.G. Stroes	2005	21
19	Lipoprotein Lipase Gene Polymorphisms and the Risk of Target Vessel Revascularization After Percutaneous Coronary Intervention Journal of the American College of Cardiology ·Pascalle S. Monraats,Jamal S. Rana,Melchior C. Nierman,Nuno Pires,Aeilko H. Zwinderman,John J.P. Kastelein,Jan Albert Kuivenhoven,Moniek P.M. de Maat,Saskia Z.H. Rittersma,Abbey Schepers,Pieter A. Doevendans,Robbert J. de Winter,René A. Tio,Rune R. Frants,Paul H.A. Quax,Arnoud van der Laarse,Ernst E. van der Wall,J. Wouter Jukema	2005	8
20	Enhanced Conversion of Triglyceride-Rich Lipoproteins and Increased Low-Density Lipoprotein Removal in LPLS447X Carriers Arteriosclerosis Thrombosis and Vascular Biology ·Melchior C. Nierman,Berthil H.C.M.T. Prinsen,Jaap Rip,Robert Jan Veldman,Jan Albert Kuivenhoven,John J.P. Kastelein,Monique G.M. de Sain–van der Velden,Erik S.G. Stroes	2005	19

About Melchior C. Nierman

Melchior C. Nierman is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice and Internal Medicine, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (10 papers), Lipid metabolism and disorders (9 papers), Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Cancer, Lipids, and Metabolism (5 papers), Blood Pressure and Hypertension Studies (5 papers), Diabetes and associated disorders (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (542 citations), Endocrinology, Diabetes and Metabolism (325 citations) and Internal Medicine (65 citations). Melchior C. Nierman has collaborated with scholars based in Netherlands, United Kingdom and Canada. Frequent co-authors include John J.P. Kastelein, Erik S.G. Stroes, Patrick Duriez, Jean‐Charles Fruchart, Jan Albert Kuivenhoven, Jaap Rip, Michael R. Hayden, Colin J.D. Ross, J. Wouter Jukema and Jaap Twisk. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Research and Practice in Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, Human Gene Therapy and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact